<?xml version="1.0" encoding="UTF-8"?>
<ref id="B133-nanomaterials-10-01072">
 <label>133.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>De Oliveira</surname>
    <given-names>M.P.</given-names>
   </name>
   <name>
    <surname>Garcion</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Venisse</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Benoît</surname>
    <given-names>J.-P.</given-names>
   </name>
   <name>
    <surname>Couet</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Olivier</surname>
    <given-names>J.-C.</given-names>
   </name>
  </person-group>
  <article-title>Tissue distribution of indinavir administered as solid lipid nanocapsule formulation in mdr1a (+/+) and mdr1a (−/−) CF-1 mice</article-title>
  <source>Pharm. Res.</source>
  <year>2005</year>
  <volume>22</volume>
  <fpage>1898</fpage>
  <lpage>1905</lpage>
  <pub-id pub-id-type="doi">10.1007/s11095-005-7147-6</pub-id>
  <pub-id pub-id-type="pmid">16132350</pub-id>
 </element-citation>
</ref>
